Literature DB >> 21423063

Light filtering in a retinal pigment epithelial cell culture model.

Jilin Zhou1, Janet R Sparrow.   

Abstract

PURPOSE: We tested for protection of blue light-exposed A2E-containing retinal pigment epithelial (RPE) from damage through the implementation of polycarbonate filters containing varying levels of a pigment that absorbs short wavelength light.
METHODS: Human adult RPE cells (ARPE-19) that had accumulated synthesized A2E were exposed to either a light line delivered from a tungsten halogen source (430 ± 20 nm; 8 mW/cm) or to the entire area of a 35 mm dish (1 mW/cm). Blue-light absorbing polycarbonate filters (2.5 × 4 cm) containing varying levels of short-wavelength light absorbing pigment (1.0, 1.9, 3.8, 7.5, 15, and 35 ppm) or no dye (PC) were placed in the light path. Cytotoxicity was measured by the 4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric microtiter assay (Roche Diagnostics Corporation, Indianapolis, IN) or by fluorescent staining of non-viable cells.
RESULTS: When filters containing blue-light absorbing dye were placed in the light path, protection of 430 nm irradiated A2E-laden RPE was observed. The extent of protection was dependent on the concentration of the dye. By MTT assay and fluorescence labeling, statistically significant differences (p < 0.05) between irradiation in the absence of a filter and irradiation in the presence of a filter were observed.
CONCLUSIONS: The series of filters tested in this work provided protection against blue light damage in a culture model.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21423063      PMCID: PMC3100371          DOI: 10.1097/OPX.0b013e3182158cdd

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  63 in total

1.  A2E, a fluorophore of RPE lipofuscin, can destabilize membrane.

Authors:  Janet R Sparrow; Bolin Cai; Young Pyo Jang; Jilin Zhou; Koji Nakanishi
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

2.  Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation.

Authors:  Pranab Maiti; Jian Kong; So Ra Kim; Janet R Sparrow; Rando Allikmets; Robert R Rando
Journal:  Biochemistry       Date:  2006-01-24       Impact factor: 3.162

3.  Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases.

Authors:  Roxana A Radu; Yun Han; Tam V Bui; Steven Nusinowitz; Dean Bok; Jay Lichter; Ken Widder; Gabriel H Travis; Nathan L Mata
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-12       Impact factor: 4.799

4.  Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium.

Authors:  Jilin Zhou; Young Pyo Jang; So Ra Kim; Janet R Sparrow
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

Review 5.  Macular degeneration: recent advances and therapeutic opportunities.

Authors:  Amir Rattner; Jeremy Nathans
Journal:  Nat Rev Neurosci       Date:  2006-10-11       Impact factor: 34.870

Review 6.  Age-related maculopathy and the impact of blue light hazard.

Authors:  Peep V Algvere; John Marshall; Stefan Seregard
Journal:  Acta Ophthalmol Scand       Date:  2006-02

7.  Restoration of lysosomal pH in RPE cells from cultured human and ABCA4(-/-) mice: pharmacologic approaches and functional recovery.

Authors:  Ji Liu; Wennan Lu; David Reigada; Jonathan Nguyen; Alan M Laties; Claire H Mitchell
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02       Impact factor: 4.799

8.  Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice.

Authors:  Mariacarmela Allocca; Monica Doria; Marco Petrillo; Pasqualina Colella; Maria Garcia-Hoyos; Daniel Gibbs; So Ra Kim; Albert Maguire; Tonia S Rex; Umberto Di Vicino; Luisa Cutillo; Janet R Sparrow; David S Williams; Jean Bennett; Alberto Auricchio
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

9.  Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy.

Authors:  J Kong; S-R Kim; K Binley; I Pata; K Doi; J Mannik; J Zernant-Rajang; O Kan; S Iqball; S Naylor; J R Sparrow; P Gouras; R Allikmets
Journal:  Gene Ther       Date:  2008-05-08       Impact factor: 5.250

10.  The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model.

Authors:  So R Kim; Young P Jang; Steffen Jockusch; Nathan E Fishkin; Nicholas J Turro; Janet R Sparrow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-28       Impact factor: 11.205

View more
  4 in total

1.  Selective blue-filtering spectacle lens protected primary porcine RPE cells against light emitting diode-induced cell damage.

Authors:  Wing Yan Yu; Samantha Sze Wan Shan; Yamunadevi Lakshmanan; Francisca Siu Yin Wong; Kai Yip Choi; Henry Ho Lung Chan
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

2.  Phototoxic action spectrum on a retinal pigment epithelium model of age-related macular degeneration exposed to sunlight normalized conditions.

Authors:  Emilie Arnault; Coralie Barrau; Céline Nanteau; Pauline Gondouin; Karine Bigot; Françoise Viénot; Emmanuel Gutman; Valérie Fontaine; Thierry Villette; Denis Cohen-Tannoudji; José-Alain Sahel; Serge Picaud
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

3.  Protective effects of blue light-blocking shades on phototoxicity in human ocular surface cells.

Authors:  Yoshimi Niwano; Atsuo Iwasawa; Kazuo Tsubota; Masahiko Ayaki; Kazuno Negishi
Journal:  BMJ Open Ophthalmol       Date:  2019-05-28

4.  Retinal Protection from LED-Backlit Screen Lights by Short Wavelength Absorption Filters.

Authors:  Celia Sanchez-Ramos; Cristina Bonnin-Arias; Vanesa Blázquez-Sánchez; Victoria Aguirre-Vilacoro; Teresa Cobo; Olivia García-Suarez; María Jesús Perez-Carrasco; Cristina Alvarez-Peregrina; José A Vega
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.